Logo image
Sign in
P-B4 Predictors of sustained viral response to 4–6 week duration therapy with Ledipasvir + Sofosbuvir + Gs-9451 +/− Gs-9669 in early and advanced fibrosis (Nih-Ihv synergy trial)
Journal article   Peer reviewed

P-B4 Predictors of sustained viral response to 4–6 week duration therapy with Ledipasvir + Sofosbuvir + Gs-9451 +/− Gs-9669 in early and advanced fibrosis (Nih-Ihv synergy trial)

Sarah Kattakuzhy, Eleanor Wilson, Lydia Tang, Angie Price, Amy Nelson, Rachel Silk, Chloe Gross, Elizabeth Akoth, Anita Kohli, Anu Osinusi, …
Journal of acquired immune deficiency syndromes (1999), Vol.71(Supplement 1), p.73
01/2016

Metrics

4 Record Views

Details